Nebivolol versus bisoprolol versus carvedilol in heart failure: effects on exercise capacity and hypoxia, chemoreceptor response, pulmonary function

Trial Profile

Nebivolol versus bisoprolol versus carvedilol in heart failure: effects on exercise capacity and hypoxia, chemoreceptor response, pulmonary function

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Oct 2013

At a glance

  • Drugs Bisoprolol (Primary) ; Carvedilol (Primary) ; Nebivolol (Primary)
  • Indications Heart failure
  • Focus Therapeutic Use
  • Acronyms CARNEBI
  • Most Recent Events

    • 29 Aug 2012 Results presented at the ESC Congress 2012: Annual Congress of the European Society of Cardiology.
    • 15 Sep 2010 Actual patient number (60) added as reported by ClinicalTrials.gov.
    • 15 Sep 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top